Angiostatin generation by human pancreatic cancer

Journal of Surgical Research

Volumn 77, Issue 1, 1998, Pages 55-58

  O'Mahony, Christine A ^a   Seidel, Amy ^a   Albo, Daniel ^a   Chang, Hong ^a   Tuszynski, George P ^a   Berger, David H ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Angiostatin; Pancreatic neoplasms; Plasminogen; Urokinase plasminogen activator

Indexed keywords

4 (2 AMINOETHYL)BENZENESULFONYL FLUORIDE; ANGIOSTATIN; APROTININ; EDETIC ACID; LEUPEPTIN; PANCREATIC ELASTASE; PHOSPHORAMIDON; PLASMINOGEN; SERINE PROTEINASE; UROKINASE;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0031880835     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1998.5334     Document Type: Article

References (18)

1. Fox, S. B., Gatter, K. C., and Harris, A. L. Tumor angiogenesis. J. Pathol 179:232, 1996.
2. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst. 82:4, 1990.
3. Folkman, J. Tumor angiogenesis. Adv. Cancer Res. 43: 175, 1985.
4. Folkman, J., and Hanahan, D. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 86: 353, 1986.
5. Weinstat-Saslow, D., and Steeg, P. S. Angiogenesis and colonization in the tumor metastatic process: basic and applied advances. FASEB J. 8:401, 1994.
6. Clap, C., Martial., J. A., Guzman, R. C., Rentier-Delrues, F., and Weiner, R. I. The 16kD N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology 133:1292, 1993.
7. Sugarbaker, E. V., Thornwaite, J., and Ketcham, A. S. Inhibitor effect of a primary tumor on metastases. In Progress in Cancer Research and Therapy. New York: Raven Press, 1977. Pp 227-240.
8. Fischer, B., Gunduz, N., and Saffer, E. A. Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases. Cancer Res. 45: 1488, 1983.
9. Woodruff, M. Cellular Variation and Adaption in Cancer. Oxford Univ. Press, New York, 1980. Pp. 64-70.
10. Lange, P. H., Helmat, K., Bosl, G., Kennedy, B. J., and Fraler, E. E. Accelerated growth of testicular cancer after cytoreductive surgery. Cancer Res. 45:1498, 1980.
11. O'Reilly, M. S., Holgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses. M., Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. Angiostatin: A novel angiogenesis inhibitor that mediates the supression of metastases by a lewis lung carcinoma. Cell 79:315, 1994.
12. O'Reilly, M. S., Holgren, L., Chen, C., and Folkman, J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nature Med. 2(6): 689, 1996.
13. Gately, S., Twardowski, P., Stack, M. S., Patrick, M., Boggio, L., Cundiff, D. L., Schnaper, H. W., Madison, L., Volpert, O., Bouck, N., Enghild, J., Kwaan, H. C., and Soff, A. Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin. Cancer Res. 56:4887, 1996.
14. Dong, Z., Kumar, R., Yang, X., and Fidler, I. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in lewis lung carcinoma. Cell 88:801, 1997.
15. Albo, D., Berger, D.H., Wang, T. N., and Tuszynski, G. P. Thrombospondin-1 and transforming growth factor beta-1 promote pancreatic cancer invasion through the regulation of the plasminogen/plasmin system. J. Surg. Res., in press.
16. Soff, G. A., Twardowski, P., Stack, S., Kwaan, H. C., and Gately, S. Cancer cell-derived mechanism for the generation of human angiostatin. Proc. Am. Assoc. Cancer Res. 38:264, 1997.
17. Mignatti, P. R., and Rifkin, D. B. Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev. 73:161, 1993.
18. Kwaan, H. C. The plasminogen-plasmin system in malignancy. Cancer Metastases Rev. 11:291, 1992.